First Time Loading...

Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 40.95 HKD -2.15% Market Closed
Updated: May 3, 2024

Innovent Biologics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innovent Biologics Inc
Cash from Investing Activities Peer Comparison

Comparables:
6160
603392
S
002252
300122
300896

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Innovent Biologics Inc
HKEX:1801
Cash from Investing Activities
-¥1.1B
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Investing Activities
¥2.4B
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-¥2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Investing Activities
-¥36.1m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
19%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-¥993.8m
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Investing Activities
-¥943.7m
CAGR 3-Years
-233%
CAGR 5-Years
-143%
CAGR 10-Years
N/A

See Also

What is Innovent Biologics Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.1B CNY

Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Cash from Investing Activities amounts to -1.1B CNY.

What is Innovent Biologics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
41%

Over the last year, the Cash from Investing Activities growth was 24%. The average annual Cash from Investing Activities growth rates for Innovent Biologics Inc have been 41% over the past three years .